Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Planned sale Chief Commercial Officer sold 1,681 shares at $35.54 ($59,743)
  2. 4 Planned sale Chief Executive Officer sold 12,947 shares at $35.54 ($460,136)
  3. 4 Planned sale Chief Medical Officer sold 4,005 shares at $35.54 ($142,338)
  4. 4 Planned sale Principal Accounting Officer sold 1,655 shares at $35.54 ($58,819)
  5. 4 Planned sale Principal Accounting Officer sold 2,272 shares at $34.39 ($78,134)
  6. 4 Planned sale Chief Commercial Officer sold 2,804 shares at $32.18 ($90,233)
  7. 4 Planned sale Director sold 200 shares at $46.28 ($9,256)
  8. 4 Open-market sale Principal Accounting Officer sold 772 shares at $56.09 ($43,301)
  9. 4 Planned sale Director sold 20,000 shares at an average $55.86 ($1,117,147)
  10. 4 Planned sale Chief Legal Officer sold 21,752 shares at an average $52.21 ($1,135,775)
  11. 4 Planned sale Chief Financial Officer sold 2,542 shares at $49.03 ($124,634)
  12. 4 Option exercise Director acquired 2,302 shares (option exercise)
  13. 4 Option exercise Director acquired 2,302 shares (option exercise)
  14. 4 Planned sale Chief Executive Officer sold 11,091 shares at $42.75 ($474,140)
  15. 4 Planned sale Chief Medical Officer sold 3,705 shares at $43.85 ($162,464)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 38 · 758 filings